Biosimilar Reference Antibodies

At DIMA Biotech, we recognize the pivotal role of benchmark reference antibodies in developing superior biologic drugs. These antibodies streamline downstream efforts, aiding in the identification of crucial elements like cell lines and reagents.
We offer a diverse range of biosimilar antibodies, meticulously assessed through binding assays. While intended for research purposes, they hold potential for various applications.
Explore DIMA’s biosimilar antibodies to advance your research and development. Join us in paving the way for biologic drug innovation.

Find the right BMK antibody for your assay
pages-1 3

 

Featured BMK Targets

CD47IL6CD52
CD30CD20TNFRSF10B
CS1TIM3CD138CD40CD45
TweakR
CD123PDL1CD33MSLNTIGITCD22
CD38B7-H3CD27CTLA4BCMATIGIT
CD70GPRC5D
EPHA3Trop2EGFRAXL
PD-1ICOSCEACAM54-1BBIL17RANKG2D
CA9IL6RCD40LIL2RABAFFBAFFR
CD37

Strict Quality Control

ELISA Binding Assay

pages-2 4

Figure 1. ELISA plate pre-coated by Human PD1, mFc-His tagged protein (Cat# PME100025) can bind to Anti-PD-1 pembrolizumab biosimilar neutralizing antibody (Cat# BME100006) in a linear range of 0.24-6.49 ng/ml.

Flow Cytometry Analysis

pages-3 3

Figure 2. HEK293 cell line transfected with human PD1(A) and irrelevant protein (B) were surface stained with anti-PD1 neutralizing antibody 1μg/ml (pembrolizumab, Cat# BME100006) followed by Alexa 488-conjugated anti-human IgG secondary antibody.